This inventor holds 1 USPTO granted patent. Top assignee: Flagship Pioneering Innovations Vi, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Vincent Xue: Innovator in Antigen Binding Molecules
Introduction
Vincent Xue is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding molecules targeting SARS-CoV-2. His innovative work is crucial in the ongoing fight against the COVID-19 pandemic.
Latest Patents
Vincent Xue holds a patent for "Antigen Binding Molecules Targeting SARS-CoV-2." This patent represents a significant advancement in the development of therapeutic and diagnostic tools for combating the virus. His work in this area showcases his commitment to addressing global health challenges.
Career Highlights
Vincent Xue is associated with Flagship Pioneering Innovations Vi, LLC, where he continues to push the boundaries of scientific research and innovation. His role at this esteemed company allows him to collaborate with other leading scientists and contribute to groundbreaking projects.
Collaborations
Vincent has worked alongside notable colleagues, including Ross Steven Federman and John Ingraham. These collaborations enhance the research environment and foster innovative solutions in the field of biotechnology.
Conclusion
Vincent Xue's contributions to the development of antigen binding molecules are vital in the fight against COVID-19. His work exemplifies the impact of innovation in addressing pressing health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile